Dr. Wang-Gillam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
- University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2002 - 2004
- Cleveland Clinic FoundationInternship, Internal Medicine, 2001 - 2002
- University of Arkansas For Medical Sciences College of MedicineClass of 2001
Certifications & Licensure
- MO State Medical License 2007 - 2026
- AR State Medical License 2003 - 2009
- OH State Medical License 2001 - 2003
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer Start of enrollment: 2011 May 10
- Registry Study - Whipple at the Splenic Artery Start of enrollment: 2010 Sep 20
- FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Neoadjuvant BMS-813160, nivolumab, gemcitabine and nab-paclitaxel for patients with pancreatic cancer.Patrick M Grierson, Crystal Wolf, Rama Suresh, Andrea Wang-Gillam, Benjamin R Tan
Clinical Cancer Research. 2025-03-24 - Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR -1, -2, and -3, in Patients with Refractory Metastatic Colorectal Cancer.Xiaofei Zhou, Xiaoyan Yang, Boris Grinshpun, Adekemi Taylor, Laura Strong
Journal of Clinical Pharmacology. 2025-02-19 - 2 citationsNeoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.Xiuli Zhang, S Peter Goedegebuure, Michael Y Chen, Rashmi Mishra, Felicia Zhang
Genome Medicine. 2024-11-14
Journal Articles
- Efficacy of Perioperative Chemotherapy for Resectable Pancreatic AdenocarcinomaAndrea Wang-Gillam, Howard S Hochster, JAMA Oncology
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersHaeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
Authored Content
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020
Press Mentions
- Verastem Oncology Reports Second Quarter 2018 Financial ResultsAugust 8th, 2018
- Verastem Oncology Presents Data on Two Lead Drug Candidates at ASCO 2018 Annual MeetingJune 4th, 2018
- Defactinib Combined with Pembrolizumab and Gemcitabine in Patients with Advanced CancerApril 18th, 2016
- Join now to see all
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: